PubMed:28854065 / 614-822 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/28854065","sourcedb":"PubMed","sourceid":"28854065","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/28854065","text":"50 mg/m2 regimens were randomly assigned to a THD group (100 mg twice daily on days 1 to 5) or placebo group, both with palonosetron (0.25 mg on day 1) and dexamethasone (12 mg on day 1; 8 mg on days 2 to 4).","tracks":[{"project":"PubMed_ArguminSci","denotations":[{"id":"T3","span":{"begin":0,"end":208},"obj":"DRI_Background"}],"attributes":[{"subj":"T3","pred":"source","obj":"PubMed_ArguminSci"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"PubMed_ArguminSci","color":"#93e0ec","default":true}]}]}}